0:41
Patty Murray
41:07 - 41:48
"I just want to emphasize what I made— comment I made in the opening remark about the pending OMB rule that would really undermine our current system and allow— take away decision-making power from our experienced scientists and just allow political appointees, whether this administration or into the future, decide where research is going to go. That is really concerning to VA researchers. We need decisions based on science, not based on somebody's mad at somebody or political decision in any administration."
“I just want to emphasize what I made— comment I made in the opening remark about the pending OMB rule that would really undermine our current system and allow— take away decision-making power from our experienced scientists and just allow political appointees, whether this administration or into the future, decide where research is going to go. That is really concerning to VA researchers. We need decisions based on science, not based on somebody's mad at somebody or political decision in any administration.”
- Speaker
- Patty Murray
- Timestamp
- 41:07 – 41:48
- Community
- Alaska News
- Captured at
- July 22, 2026
From the transcript
Okay, well, we do know last year 9 researchers were terminated with no warning and their research stopped, so you can't say that cutting personnel doesn't impact research. But I just— I only have 5 seconds left. I just want to emphasize what I made— comment I made in the opening remark about the pending OMB rule that would really undermine our current system and allow— take away decision-making power from our experienced scientists and just allow political appointees, whether this administration or into the future, decide where research is going to go. That is really concerning to VA researchers. We need decisions based on science, not based on somebody's mad at somebody or political decision in any administration.
Related Coverage
Senate panel examines VA research funding, hiring delays, and prostate cancer program
The Senate Veterans' Affairs Committee held a broad hearing Wednesday on the future of VA research, covering hiring delays, budget cuts, NIH funding instability, and clinical trial disruptions. Senators also questioned whether a $5 million FY2024 appropriation for the VA prostate cancer precision oncology program was spent as Congress intended.
by Walter AlaskaNews3h ago2 min readAIWashington, District of Columbia
